Defencath

Active Ingredient(s): Taurolidine + Heparin Sodium
FDA Approved: * November 15, 2023
Pharm Company: * CORMEDIX INC
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Defencath Intraluminal Solution
NDC: 72990-103
Labeler:
Cormedix Inc.
Defencath Intraluminal Solution
NDC: 72990-105
Labeler:
Cormedix Inc.